Data as of Dec 11
| -0.63 / -1.06%|
The 7 analysts offering 12-month price forecasts for Intercept Pharmaceuticals Inc have a median target of 72.00, with a high estimate of 107.00 and a low estimate of 55.00. The median estimate represents a +22.80% increase from the last price of 58.63.
The current consensus among 7 polled investment analysts is to Buy stock in Intercept Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.